Jialiang Medical Named AI+Healthcare Innovation Leader by Rongzhong POWER50 List
GenLight
Innovative Medical Device Solution Provider
On July 25, 2025, the "2024-2025 China POWER50 Enterprise List" jointly released by Rongzhong Finance, a top financial media in China, and the two authoritative institutions, Zero2IPO and CVSource, was officially announced.
Genlight Neurotech with its own expertise inResearch and Application of Invasive Brain-Computer Interface Technology、Adaptive AI Algorithms and Real-Time Decoding of Neural Signals、Construction of Multi-Scenario Neuromodulation PlatformandIndustrialization of Major Clinical BreakthroughsIn recognition of its outstanding performance and industry benchmark leadership, it was awarded the title of "Innovative Leader in AI + Healthcare" by Rongzhong Finance.
In the future, Genlight Neurotech will continue to deeply cultivate the underlying technology of neural interaction, constantly expand its cross-scenario industry influence, and contribute Genlight wisdom to the integration of humans and machines in the intelligent era!
More rankings:Genlight Neurotech
About Rongzhongbang
The Rongzhong List is one of the most credible evaluation systems in China's equity investment field. Since its first release in 2015, it has developed over a decade to form a complete ecosystem ranging from data collection, multi-dimensional assessment to value dissemination. It features a unique "3+2" evaluation model and is reviewed by a jury composed of 60 top institutional partners. This list not only documents the growth trajectory of China's new economy but also continuously promotes value co-creation between capital and industry through innovative mechanisms such as the "High-Quality Enterprise Cultivation Program."
About Genlight Neurotech
Genlight Neurotech was founded in Hangzhou in 2020 as a high-tech platform enterprise dedicated to industrializing cutting-edge technologies in the fields of brain science and neurosurgery.
The company has built three advanced technology platforms: brain-computer modulation, medical lasers, and brain-computer chips, providing innovative device solutions for various neurological disorders. Developed products include the Magnetic Resonance-guided Laser Ablation Surgery System (LITT) for minimally invasive brain surgery, an implantable closed-loop self-responsive neurostimulation system for treating epilepsy and Parkinson's disease, and deep brain electrodes, some of which have entered the formal clinical trial stage.
Genlight Neurotech adheres to the concept of independent innovation and benefiting patients, with a global layout and coordinated development of production and research, striving to become a trusted leader in solutions within the field of neurology.
'%20fill='%23FFFFFF'%3E%3Crect%20x='249'%20y='126'%20width='1'%20height='1'%3E%3C/rect%3E%3C/g%3E%3C/g%3E%3C/svg%3E)